Delivery Order SPE2DB22D3004-SPE2DB24FQU09
Award Date
6/18/24
Potential Completion Date
6/20/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at up to $3,212.48, is for the delivery of Emgality 120 mg/ml injectable medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of Emgality 300 mg (100 mg x 3 syringes) to the Defense Logistics Agency (DLA). The contract, valued at $2,320.50, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for...
This federal contract award, valued at $2,777.21, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Emgality 300 mg (100 mg x 3 syringes) medication. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 14, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award Management...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,754.24 firm fixed price contract is for the supply of Emgality 300 mg (100 mg x 3 syringes) medication. This order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a wide range of pharmaceutical and medical products to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,002.34, is a delivery order under an Indefinite Delivery Contract (IDC) for the supply of Emgality 300 mg (100 mg x 3 syr) medication. The contract has a period of performance through April 9, 2025 and does not have any set-aside designation. AmerisourceBergen is the prime contractor, and the contract supports the procurement of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Emgality 300 mg (100 mg x 3 syringes) medication. The contract has a ceiling value of $1,495.32 and a performance period through March 13, 2024. This award is a delivery order under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,593.50 Firm Fixed Price Delivery Order covers the supply of Emgality 120 mg/mL injectable medication, with a period of performance through December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, valued at $6,786.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Emgality 300 mg (100 mg x 3 syringes) and has an ultimate completion date of December 1, 2023. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,250.98, is a firm fixed-price delivery order for the pharmaceutical product Emgality 300 mg (100 mg x 3 syringes). The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp's Corporate Office Division. The $13,831.14 firm-fixed-price delivery order is for the provision of the pharmaceutical product Emgality 300 mg (100 mg x 3 syringes) to support the agency's defense mission. The award is under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a single-award contract valued up...